All IBC applications are completed online in the Research Information Management System (RIMS).
Principal Investigators (PIs) must complete a RIMS PI Account Registration in order to access the IBC application. The PI can designate others to assist in completing the application, however, only the PI can submit the application. IBC requires that all PIs be members of the BU/BMC faculty. Projects from post-docs or other non-faculty members will require a faculty PI sponser.
PIs seeking IBC approval for the first time also need to submit a two-page NIH biosketch with their application.
All personnel must complete the Lab Safety Training(s) and ROHP Clearance requirements. Additionally, PI must complete “Recombinant DNA / IBC Policies Training”. Other training will be required based on the nature of project.Personnel will need to have a RIMS Training Profile in order to complete these requirements.
All applications must be recieved by the deadline to allow time for review by the committee members and a Biological Use Authorization Site Assessment by EHS. Deadlines can be found under Meeting Dates & Deadlines. Each application will be assigned to a primary reviewer and a secondary reviewer. Reviewer comments will be discussed at a convened IBC meeting.
IBC approval of recombinant or synthetic nucleic acid moleccules and biohazardous research projects is effective for three years. However, PIs must complete an IBC Annual Renewal each year to continue work for up to three years after the initial approval. After three years, the application must be resubmitted and reviewed by the committee.